Torrent Pharma today reported consolidated net profit of Rs 357 crore for the quarter ended March 31, mainly on account of robust sales in the US market.
It had posted net profit of Rs 130 crore for the January- March period of the previous fiscal, the company said in a BSE filing.
Total income from operations stood at Rs 1,499 crore for the quarter under consideration, compared with Rs 1,154 crore for the year-ago period.
For the entire 2015-16 fiscal, the consolidated net profit of the company was at Rs 1,722 crore. It was Rs 751 crore in the year-ago fiscal.
Total income from operations stood at Rs 6,676 crore last fiscal. It was Rs 4,653 crore for the previous fiscal.
“The figures for the quarter ended December 31, 2015 and March 31, 2016 are after giving effect of scheme of amalgamation while figures for the corresponding quarters are before giving effect of amalgamation,” Torrent Pharma said.
Hence, the figures of the corresponding period and previous year are not comparable with the figures of the current period, it added.
In a separate filing, the company said its board after considering the distribution of interim dividend and special interim dividend of Rs 20 and Rs 15 (total Rs 35 per share) respectively per equity share of Rs 5 each for the financial year 2015-16, did not recommend distribution of any further dividend.
Torrent Pharma stock closed 0.77 per cent higher at Rs 1,333.55 on BSE.